CellaVision AB (CLVSF)
14.00
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
CellaVision Free Cash Flow : 10.67M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.67M |
| March 31, 2026 | 13.91M |
| December 31, 2025 | 12.95M |
| September 30, 2025 | 12.61M |
| June 30, 2025 | 12.38M |
| March 31, 2025 | 10.02M |
| December 31, 2024 | 11.16M |
| September 30, 2024 | 14.47M |
| June 30, 2024 | 17.19M |
| March 31, 2024 | 15.86M |
| December 31, 2023 | 10.24M |
| September 30, 2023 | 5.564M |
| June 30, 2023 | 2.207M |
| March 31, 2023 | 3.766M |
| December 31, 2022 | 6.880M |
| September 30, 2022 | 9.800M |
| June 30, 2022 | 12.54M |
| March 31, 2022 | 9.731M |
| December 31, 2021 | 8.670M |
| September 30, 2021 | 7.243M |
| June 30, 2021 | 1.611M |
| March 31, 2021 | 4.840M |
| December 31, 2020 | 3.968M |
| September 30, 2020 | 4.078M |
| June 30, 2020 | 8.296M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.116M |
| December 31, 2019 | 11.42M |
| September 30, 2019 | 10.05M |
| June 30, 2019 | 9.563M |
| March 31, 2019 | 10.91M |
| December 31, 2018 | 5.792M |
| September 30, 2018 | 7.793M |
| June 30, 2018 | 6.105M |
| March 31, 2018 | 4.850M |
| December 31, 2017 | 6.854M |
| September 30, 2017 | 7.385M |
| June 30, 2017 | 7.308M |
| March 31, 2017 | 7.605M |
| December 31, 2016 | 7.204M |
| September 30, 2016 | 5.211M |
| June 30, 2016 | 8.262M |
| March 31, 2016 | 6.001M |
| December 31, 2015 | 9.387M |
| September 30, 2015 | 7.459M |
| June 30, 2015 | 5.396M |
| March 31, 2015 | 5.007M |
| December 31, 2014 | 4.046M |
| September 30, 2014 | 6.585M |
| June 30, 2014 | 4.808M |
| March 31, 2014 | 5.733M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ALR Technologies SG Ltd. | -- |
| Carasent AB | 5.626M |
| PHC Holdings Corp. | 263.74M |
| SyntheticMR AB | -1.946M |
| HealthStream, Inc. | 41.60M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.945M |
| Cash from Investing (Quarterly) | -1.861M |
| Cash from Financing (Quarterly) | -7.414M |
| Free Cash Flow Per Share (Quarterly) | 0.0454 |
| Free Cash Flow to Equity (Quarterly) | -1.963M |
| Free Cash Flow to Firm (Quarterly) | 1.134M |
| Free Cash Flow Yield | 3.20% |